Today, the IRIC and IRICoR welcome Jeffrey M. Bockman, Senior VP and Head of the Oncology practice at DefinedHealth, for a business seminar.

He will present a conference titled “Immuno-Oncology’s Signal-to-Noise Problem: Developing Proof of Relevance for Novel MOAs”.

 

Jeffrey M. Bockman, PhD

Mr. Bockman has extensive commercial and strategic perspective on the pharmaceutical and biotech industries. He has directed hundreds of in-depth licensing opportunities and valuation assessments during his tenure at DefinedHealth. He often speaks at conferences on scientific and commercial issues in cancer, biologics and personalized medicine.